GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Semler Scientific Inc (NAS:SMLR) » Definitions » Operating Income
中文

Semler Scientific (Semler Scientific) Operating Income

: $22.99 Mil (TTM As of Dec. 2023)
View and export this data going back to 2014. Start your Free Trial

Semler Scientific's Operating Income for the three months ended in Dec. 2023 was $2.66 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 was $22.99 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. Semler Scientific's Operating Income for the three months ended in Dec. 2023 was $2.66 Mil. Semler Scientific's Revenue for the three months ended in Dec. 2023 was $15.06 Mil. Therefore, Semler Scientific's Operating Margin % for the quarter that ended in Dec. 2023 was 17.65%.

Good Sign:

Semler Scientific Inc operating margin is expanding. Margin expansion is usually a good sign.

Semler Scientific's 5-Year average Growth Rate for Operating Margin % was 3.40% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Semler Scientific's annualized ROC % for the quarter that ended in Dec. 2023 was 83.95%. Semler Scientific's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 238.78%.


Semler Scientific Operating Income Historical Data

The historical data trend for Semler Scientific's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Semler Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.71 15.96 19.45 17.20 22.99

Semler Scientific Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.62 6.26 7.18 6.90 2.66

Semler Scientific Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $22.99 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Semler Scientific  (NAS:SMLR) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Semler Scientific's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

ROC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2023 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=10.628 * ( 1 - -50% )/( (20.013 + 17.969)/ 2 )
=15.942/18.991
=83.95 %

where

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Semler Scientific's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=10.628/( ( (3.263 + max(-0.138, 0)) + (3.005 + max(2.634, 0)) )/ 2 )
=10.628/( ( 3.263 + 5.639 )/ 2 )
=10.628/4.451
=238.78 %

where Working Capital is:

Working Capital(Q: Sep. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(5.966 + 0.439 + 1.946) - (3.629 + 1.12 + 3.74)
=-0.138

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(6.125 + 0.445 + 2.174) - (2.896 + 1.12 + 2.094)
=2.634

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Semler Scientific's Operating Margin % for the quarter that ended in Dec. 2023 is calculated as:

Operating Margin %=Operating Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=2.657/15.057
=17.65 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Semler Scientific Operating Income Related Terms

Thank you for viewing the detailed overview of Semler Scientific's Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Semler Scientific (Semler Scientific) Business Description

Traded in Other Exchanges
Address
2340-2348 Walsh Avenue, Suite 2344, Santa Clara, CA, USA, 95051
Semler Scientific Inc is a US-based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test.
Executives
Eric Semler director 4625 FIELDSTON ROAD, BRONX NY 10471
Renae Cormier officer: Chief Financial Officer C/O SEMLER SCIENTIFIC, INC., 2340-2348 WALSH AVE, SUITE 2344, SANTA CLARA CA 95051
Douglas Murphy-chutorian director, 10 percent owner, officer: Chief Executive Officer C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, SUITE 110, SAN JOSE CA 95112
Wayne T Pan director 2330 NW EVERETT STREET, PORTLAND OR 97210
William H.c. Chang & Diana Shon Chang Ttee Chang Family Trust U/a Dtd 10/23/2006 10 percent owner C/O SEMLER SCIENTIFIC, INC., 911 BERN CT., SAN JOSE CA 95112
Chang 2020 Delaware Lp 10 percent owner C/O SEMLER SCIENTIFIC, INC., 2340-2348 WALSH AVENUE, SUITE 2344, SANTA CLARA CA 95051
Arthur N Leibowitz director C/O I-TRAX INC, ONE LOGAN SQUARE STE 2615, PHILADELPHIA PA 19103
Chang 2020 Gp Llc 10 percent owner C/O SEMLER SCIENTIFIC, INC., 2340-2348 WALSH AVENUE, STE. 2344, SANTA CLARA CA 95051
Cindy Moon director C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, SAN JOSE CA 95112
Daniel S Messina director C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, STE. 110, SAN JOSE Z4 95112
Daniel E Conger officer: Vice President, Finance C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, SUITE 110, SAN JOSE CA 95112
William H Chang 10 percent owner C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, SUITE 110, SAN JOSE CA 95112
Diana Shon Chang 10 percent owner 1301 SHOREWAY RD., SUITE 150, BELMONT CA 94002
Andrew B. Weinstein officer: Senior VP, Finance and Acct. C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, SUITE 110, SAN JOSE CA 95112
Herbert J Semler director, 10 percent owner C/O SEMLER SCIENTIFIC, INC., 2330 NW EVERETT ST., PORTLAND OR 97210